Perrigo (PRGO) Change in Accured Expenses (2013 - 2026)

Perrigo's (PRGO) quarterly Change in Accured Expenses came in at -$24.9 million in Q1 2026, up 55.61% year-on-year from -$16.0 million in Q1 2025, and down 0.81% on a QoQ basis from -$24.7 million in Q4 2025.

Perrigo (PRGO) Change in Accured Expenses (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Change in Accured Expenses data on file, last reported at -$24.9 million in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 55.61% year-over-year to -$24.9 million in Q1 2026; TTM through Mar 2026 was -$32.2 million, a 455.17% decrease from a year earlier, with the FY2025 full-year figure at -$63.4 million, down 4776.92% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$24.9 million, down from -$24.7 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for PRGO reached as high as $55.7 million in Q3 2023 and fell as low as -$66.0 million in Q4 2023.
  • Historically, Change in Accured Expenses has averaged -$10.6 million across 5 years, with a median of -$15.1 million in 2025.
  • On a YoY basis, Change in Accured Expenses climbed as much as 3376.47% in 2023 and fell as far as 2969.57% in 2023.
  • Year by year, Change in Accured Expenses stood at $2.3 million in 2022, then plunged by 2969.57% to -$66.0 million in 2023, then surged by 64.09% to -$23.7 million in 2024, then declined by 4.22% to -$24.7 million in 2025, then fell by 0.81% to -$24.9 million in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$24.9 million in Q1 2026, -$24.7 million in Q4 2025, and -$15.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -144.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -12.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn -24.90 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 -24.90 Mn
Mar 28, 2026 -24.90 Mn
Dec 31, 2025 -24.70 Mn
Dec 31, 2025 -24.70 Mn
Sep 27, 2025 -15.10 Mn
Sep 27, 2025 -15.10 Mn
Jun 28, 2025 32.50 Mn
Jun 28, 2025 32.50 Mn
Mar 29, 2025 -56.10 Mn
Mar 29, 2025 -56.10 Mn
Dec 31, 2024 -23.70 Mn
Dec 31, 2024 -23.70 Mn
Sep 28, 2024 39.30 Mn
Sep 28, 2024 39.30 Mn
Jun 29, 2024 34.70 Mn
Jun 29, 2024 34.70 Mn
Mar 30, 2024 -51.60 Mn
Mar 30, 2024 -51.60 Mn
Dec 31, 2023 -66.00 Mn
Dec 31, 2023 -66.00 Mn